• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro stability of ranitidine hydrochloride in enteral nutrient formulas.

作者信息

Crowther R S, Bellanger R, Szauter K E

机构信息

Department of Internal Medicine, University of Texas Medical Branch, Galveston 77555, USA.

出版信息

Ann Pharmacother. 1995 Sep;29(9):859-62. doi: 10.1177/106002809502900905.

DOI:10.1177/106002809502900905
PMID:8547732
Abstract

OBJECTIVE

To determine the chemical stability and physical compatibility of ranitidine in enteral nutrient formulas.

MEASUREMENTS

A stability-indicating HPLC assay was used to measure the recovery of ranitidine from tablet (dissolved in water) or syrup after up to 24 hours of in vitro incubation in a variety of enteral nutrient formulas. Ranitidine binding to components of the formulas was measured after ultrafiltration.

RESULTS

Eight enteral nutrient formulas were studied, and more than 90% of added ranitidine was recovered from each formula after 24 hours. The amount of ranitidine bound to components of the formulas varied between 8% and 29%. No gross physical incompatibilities were seen and the pH of each formula changed by less than 0.1 pH units over 24 hours.

CONCLUSIONS

Ranitidine from either tablet or syrup was stable in the enteral nutrient formulas studied. Administration of ranitidine by admixture into these enteral formulas may be feasible.

摘要

相似文献

1
In vitro stability of ranitidine hydrochloride in enteral nutrient formulas.
Ann Pharmacother. 1995 Sep;29(9):859-62. doi: 10.1177/106002809502900905.
2
Stability of drugs with enteral nutrient formulas.药物与肠内营养配方的稳定性
DICP. 1990 Feb;24(2):130-4. doi: 10.1177/106002809002400202.
3
Recovery of warfarin from an enteral nutrient formula.
Am J Hosp Pharm. 1989 Jul;46(7):1395-9.
4
Stability of ranitidine hydrochloride in total nutrient admixtures.
Am J Hosp Pharm. 1988 May;45(5):1100-2.
5
Stability of ranitidine hydrochloride in total parenteral nutrient solution.
Am J Hosp Pharm. 1985 Mar;42(3):590-2.
6
Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.盐酸雷尼替丁与氨基酸在肠外营养液中的稳定性
Am J Hosp Pharm. 1985 Dec;42(12):2683-7.
7
Compatibility of oral morphine sulfate solution with enteral feeding products.口服硫酸吗啡溶液与肠内营养产品的相容性。
Ann Pharmacother. 1994 Apr;28(4):451-5. doi: 10.1177/106002809402800404.
8
Challenges of Quantifying FODMAPs in Enteral Nutrition Formulas: Evaluation of Artifacts and Solutions.量化肠内营养配方中 FODMAP 的挑战:人工制品的评估与解决方案。
JPEN J Parenter Enteral Nutr. 2017 Nov;41(8):1262-1271. doi: 10.1177/0148607116658763. Epub 2016 Jul 12.
9
Recovery of phenytoin from feeding formulas and protein mixtures.苯妥英从喂养配方和蛋白质混合物中的回收率。
Am J Health Syst Pharm. 2003 Sep 15;60(18):1850-2. doi: 10.1093/ajhp/60.18.1850.
10
Recovery of phenytoin from an enteral nutrient formula.
Am J Hosp Pharm. 1986 Mar;43(3):685-8.